From Spark’s Gene Therapy to Restore Vision Wins Unanimous FDA Panel Vote:

Jeff Marrazzo, Kathy High
Jeff Marrazzo, Kathy High

Photo of Spark Therapeutics president of research and development Kathy High (l) and CEO Jeff Marrazzo (r) c/o Spark Therapeutics.